A Series of Neoadjuvant Chemoradiotherapy Combined With Immunotherapy for Locally Advanced Rectal Cancer: From a Multicenter Phase II Cohort to a Phase III Randomized Controlled Study
Conditions: Locally Advanced Rectal Carcinoma Interventions: Drug: Tislelizumab Sponsors: Beijing Friendship Hospital; Beijing Chao Yang Hospital; Peking University Cancer Hospital& Institute; CHINA-JAPEN FRIENDSHIP HOSPITAL; Peking Union Medical College Hospital; Cancer Institute and Hospital, Chinese Academy of Medical Sciences; Fudan University; Changhai Hospital; RenJi Hospital; Sir Run Run Shaw Hospital, affiliated with the Zhejiang University School of Medicine; Shandong Provincial Hospital; Zhongnan Hospital of Wuhan University& Second Clinical Hospital of Wuhan University; The First Affiliated Hospital of Zhengzhou...
Source: ClinicalTrials.gov - March 15, 2024 Category: Research Source Type: clinical trials
Personalized Targeted Immunomodulation in COVID-19 ARDS
Conditions: COVID-19 Acute Respiratory Distress Syndrome Interventions: Drug: Single target immunomodulation; Drug: Standard of care Sponsors: Erasmus Medical Center; Amsterdam UMC; Leiden University Medical Center; St. Antonius Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2024 Category: Research Source Type: clinical trials
Effects of Volatile Anaesthetics on Incidence of Postoperative Depression and Anxiety in Elderly Patients
Conditions: Cohort Studies Interventions: Drug: volatile anaesthetic (sevoflurane, isoflurane, desflurane) Sponsors: Chinese PLA General Hospital; Beijing Tsinghua Changgeng Hospital; Peking University First Hospital; The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School; Xiangya Hospital of Central South University; Beijing Anzhen Hospital; Central South University; Peking University People ' s Hospital; Zhejiang University; Fudan University; Sun Yat-sen University; Wuhan Union Hospital, China; China-Japan Friendship Hospital; The Affiliated Hospital Of Guizhou Medical University; First Affiliate...
Source: ClinicalTrials.gov - March 13, 2024 Category: Research Source Type: clinical trials
Empowerment and Burnout of Midwives at the End of Health Emergency From COVID-19
Conditions: COVID-19 Interventions: Other: Evaluation of midwifes ' burnout Sponsors: IRCCS Burlo Garofolo Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 13, 2024 Category: Research Source Type: clinical trials
Kawasaki Disease During the COVID-19 Epidemic
Conditions: Kawasaki Disease Interventions: Other: Clinical evaluation Sponsors: IRCCS Burlo Garofolo Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 13, 2024 Category: Research Source Type: clinical trials
Assessing the Impact of COVID-19 on HMPV Incidence and Severity Among Adults
Conditions: The Prevalance of HMPV After COVID-19 Pandemic; The Importance of Accurate Diagnosis for HPMV Interventions: Other: Observation Sponsors: Acibadem University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 13, 2024 Category: Research Source Type: clinical trials
RECOVER-AUTONOMIC: Platform Protocol, Appendix A (IVIG)
Conditions: Long COVID; Long Coronavirus Disease 2019 (Covid19); Long Covid-19 Interventions: Drug: IVIG (intravenous immunoglobulin); Drug: IVIG Placebo; Behavioral: Coordinated Care; Behavioral: Usual Care Sponsors: Duke University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 12, 2024 Category: Research Source Type: clinical trials
RECOVER-AUTONOMIC: Platform Protocol, Appendix B (Ivabradine)
Conditions: Long COVID; Long Covid19; Long Covid-19 Interventions: Drug: Ivabradine; Drug: Ivabradine Placebo; Behavioral: Coordinated Care; Behavioral: Usual Care Sponsors: Duke University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 12, 2024 Category: Research Source Type: clinical trials
RECOVER-AUTONOMIC Platform Protocol
Conditions: Long COVID; Long Covid19; Long Covid-19 Interventions: Drug: IVIG + Coordinated Care; Drug: IVIG Placebo + Coordinated Care; Drug: Ivabradine + Coordinated Care; Drug: Ivabradine Placebo + Coordinated Care; Drug: IVIG + Usual Care; Drug: IVIG Placebo + Usual Care; Drug: Ivabradine + Usual Care; Drug: Ivabradine Placebo + Usual Care Sponsors: Duke University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 12, 2024 Category: Research Source Type: clinical trials
SVF for Treating Pulmonary Fibrosis Post COVID-19
Conditions: Pulmonary Fibrosis Interventions: Biological: Autologous adipose-derived SVF IV administration Sponsors: Michael H Carstens; Ministerio de Salud de Nicaragua; Wake Forest University; National Autonomous University of Nicaragua Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 11, 2024 Category: Research Source Type: clinical trials
Clinical Trial to Explore the Skin Test Dosage of EEC in People Aged 18 to 65 Years Old and the Safety and Preliminary Efficacy in People Aged 3 to 75 Years Old.
Conditions: Tuberculosis Interventions: Biological: 2.5 μg/ml EEC; Biological: 5μg/ml EEC; Biological: 5 unit（U） EC Sponsors: Chengdu CoenBiotech Co., Ltd; Beijing Chest Hospital, Capital Medical University; Wuhan Institute for Tuberculosis Control; The Public Health Clinical Center of Chengdu; Xuzhou Infectious Disease Hospital; Jiangsu Province Centers for Disease Control and Prevention; Changde First People ' s Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 11, 2024 Category: Research Source Type: clinical trials
Safety of UFRJvac, Trivalent COVID-19 Vaccine
Conditions: Healthy People Sponsors: Azidus Brasil; Universidade Federal do Rio de Janeiro Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 11, 2024 Category: Research Source Type: clinical trials
Understanding Adaptive Immune Response After COVID-19 Vaccination Boosters to Improve Vaccination Strategies in Vulnerable Groups.
Conditions: COVID-19 Interventions: Other: Analisys of cellular response and humoral response to SARS-CoV-2 vaccine booster doses Sponsors: IRCCS Sacro Cuore Don Calabria di Negrar Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 8, 2024 Category: Research Source Type: clinical trials
MRD Response-adapted Allo-HSCT for Adverse-risk AML
Conditions: Acute Myeloid Leukemia Interventions: Other: Intervention group; Other: Control group Sponsors: Peking University People ' s Hospital; Ruijin Hospital; Wuhan TongJi Hospital; Anhui Provincial Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 8, 2024 Category: Research Source Type: clinical trials
A Two Year Longitudinal Clinical Study of Neurocognitive and Psychiatric Symptoms in Post COVID-19 Patients
Conditions: COVID-19 Interventions: Other: Follow-up Sponsors: Region Örebro County; Örebro University, Sweden; Karolinska Institutet; Karolinska University Hospital; Sahlgrenska University Hospital, Sweden Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 7, 2024 Category: Research Source Type: clinical trials
